Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Proton FLASH preserves neurocognition across delivery techniques: implications for clinical translation in pediatric brain tumors.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Mirdametinib and abemaciclib cooperate in atypical teratoid rhabdoid tumor to decrease proliferation and suppress tumor growth.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
B7-H3-targeted natural killer cells effectively kill atypical teratoid / rhabdoid tumors and extend survival in orthotopic xenografts.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.
Journal: Neuro-oncology
Published: January 19, 2026
Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma.
Journal: Neuro-oncology
Published: January 19, 2026
Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.
Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.
Journal: Neuro-oncology practice
Published: December 29, 2025
Berzosertib enhances the sensitivity of pediatric diffuse midline glioma H3K27-altered cells to radiotherapy.
Journal: Cell death & disease
Published: September 01, 2025
Disordered DNA methylation leads to targetable transcriptional plasticity in ATRT.
Journal: Acta neuropathologica communications
Published: August 25, 2025
Developing a zebrafish xenograft model of diffuse midline glioma.
Journal: bioRxiv : the preprint server for biology
Published: April 16, 2025
BCOR loss promotes both retinoblastoma growth and susceptibility to IGF1R inhibition.
Journal: Neuro-oncology
Published: April 11, 2025
The CoREST complex inhibitor, corin, decreases tumor growth, increases cellular differentiation and extends lifespan in ATRT xenograft models.
Journal: Neuro-oncology
Published: March 29, 2025
The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft models.
Journal: bioRxiv : the preprint server for biology
Published: January 07, 2025
Last Updated: 09/26/2026